Inactive Instrument
Global Blood Therapeutics, Inc. Stock
Stocks
GBT
US37890U1088
Biotechnology & Medical Research
| 1 day | +0.01% |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 10/5/22 | Issuer sale | Chief Financial Officer | 448,218 | 0.6643% | ||
| 10/5/22 | Issuer sale | Director | 29,709 | 0.0440% | ||
| 10/5/22 | Issuer sale | Director | 62,923 | 0.0933% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.01% | +0.56% | - | - | 4.62B | |
| +0.88% | -0.34% | +40.64% | +73.05% | 65.28B | |
| -0.23% | -0.23% | +9.54% | +77.07% | 54.57B | |
| -0.35% | +1.22% | +9.33% | +101.08% | 53.59B | |
| -2.06% | +2.90% | +24.07% | +48.36% | 45.03B | |
| -1.79% | +0.19% | +19.32% | +123.62% | 42.17B | |
| -1.65% | +0.96% | +237.56% | +823.66% | 39.42B | |
| -2.26% | -4.14% | +15.38% | +45.53% | 32.71B | |
| -2.70% | -10.77% | +19.80% | -6.47% | 24.01B | |
| +0.44% | +14.45% | +59.25% | +48.38% | 26.5B | |
| Average | -0.97% | +2.38% | +48.32% | +148.25% | 42.59B | |
| Weighted average by Cap. | -0.86% | +2.27% | +45.62% | +148.36% |
Employees
457
